FinTrust Capital Advisors’s Amedisys AMED Stock Holding History

FinTrust Capital Advisors’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-69	Closed	-$17K	–	1151
2021 Q2	$17K	Hold	69	–	–	﹤0.01%	791
2021 Q1	$18K	Sell	69 -21	-23%	-$5.92K	0.01%	739
2020 Q4	$26K	Sell	90 -26	-22%	-$6.67K	0.01%	611
2020 Q3	$27	Sell	116 -269	-70%	-$61.2K	0.01%	591
2020 Q2	$76K	Buy	385 +199	+107%	+$37.1K	0.03%	396
2020 Q1	$34K	Hold	186	–	–	0.02%	511
2019 Q4	$31K	Buy	+186	New	+$27.7K	0.01%	547

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FinTrust Capital Advisors's AMED Position: Q3 2021 in Review

FinTrust Capital Advisors sold out of Amedisys (AMED) in Q3 2021, closing a stake of 69 shares — an estimated $17K sold.

FinTrust Capital Advisors first reported a position in AMED in Q4 2019 and held it in 7 quarters. The position peaked at $76K in Q2 2020. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

FinTrust Capital Advisors reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
FinTrust Capital Advisors sold 69 Amedisys shares in Q3 2021, an estimated $17K.
FinTrust Capital Advisors first reported a position in Amedisys in Q4 2019 and held it in 7 quarters.
FinTrust Capital Advisors's Amedisys position peaked at $76K in Q2 2020.
351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on FinTrust Capital Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.